(IN BRIEF) Dr. Sariqa Wagley, a microbiologist at the University of Exeter, has been awarded a £676,580 NERC Independent Research Fellowship to investigate dormant bacteria causing cholera and gastroenteric outbreaks. The research will focus on Vibrio species, responsible for human … Read the full press release
(IN BRIEF) AWAKE, a plasma accelerator at CERN, is gearing up for its second phase of data taking with an upgraded plasma source. The accelerator utilizes plasma wakefield acceleration, a novel method that accelerates particles by riding on waves created … Read the full press release
Posted in Business, Industrial, Management, News, Pharma & Biotech, Science, Switzerland
Tagged Alban Sublet, AWAKE Accelerator, CERN, Edda Gschwendtner, Plasma Source, plasma wakefield
(IN BRIEF) Roche and Alnylam have entered into a partnership to jointly develop and commercialize zilebesiran, an investigational RNAi therapeutic for the treatment of hypertension. Hypertension affects a significant number of adults worldwide and is a major risk factor for … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland
Tagged Alnylam, Hypertension Treatment, partnership, RNAi Therapy, Roche, Teresa Graham, Yvonne Greenstreet MBChB, zilebesiran
(IN BRIEF) QIAGEN has launched the QIAseq Normalizer Kits, a new solution for researchers to efficiently pool different DNA libraries for optimal results in next-generation sequencing (NGS) runs. The kit accelerates the process of normalizing DNA concentrations across libraries, reducing … Read the full press release
(IN BRIEF) H. Lundbeck A/S has announced the initiation of CEO succession, with Deborah Dunsire choosing to retire from her role as President and CEO. Charl van Zyl has been appointed as the new President and CEO, and Dunsire will … Read the full press release
Posted in Business, Denmark, Healthcare, Management, Pharma & Biotech
Tagged appointment, biopharma, Board of Directors, CEO, Charl van Zyl, CNS, Deborah Dunsire, Eli Lilly, H. Lundbeck A/S, immunology, Lars Rasmussen, Lundbeck, Neurology, Novartis
(IN BRIEF) Chr. Hansen has received approval from the EU for their 6’-SL HMO, the final addition to their MyOli™ 5 HMO Mix. This authorization allows the highest use level of 6’-SL in infant formula and follow-on formula in the … Read the full press release
(IN BRIEF) Newcastle University researchers, Professor Akane Kawamura and Dr James Dawson, have been awarded prestigious prizes by the Royal Society of Chemistry. Professor Kawamura received the Jeremy Knowles Award for her innovative work in developing technologies and chemical probes … Read the full press release
Posted in Awards, Education, Energy, Gas & Oil, Pharma & Biotech, Science, Technology, United Kingdom
Tagged chemical sciences, chemistry, Dr Helen Pain, Dr James Dawson, Harrison-Meldola Memorial Prize, Jeremy Knowles Award, Newcastle University, Professor Akane Kawamura, Royal Society of Chemistry Prizes
(IN BRIEF) AstraZeneca’s new drug application (NDA) for capivasertib, in combination with Faslodex, has been accepted and granted Priority Review by the US FDA for the treatment of advanced breast cancer. The NDA is being reviewed under Project Orbis, which … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged 2022 San Antonio Breast Cancer Symposium, AstraZeneca, breast cancer, CAPItello-291 Phase III, capivasertib, CDK4/6 inhibitors, endocrine therapies, Faslodex, FDA, Food and Drug Administration, fulvestran, hormone receptor, metastatic breast cancer, NDA, New Drug Application, Priority Review, Susan Galbraith, The New England Journal of Medicine
(IN BRIEF) AstraZeneca and Quell Therapeutics have announced a collaboration to develop innovative treatments for Type 1 Diabetes and Inflammatory Bowel Disease. Quell’s T-regulatory cell engineering technology will be used to create potential curative therapies. AstraZeneca has the option to … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, autoimmune disease, cell therapies, Foxp3 Phenotype Lock, Iain McGill, IBD, IND, inflammatory bowel disease, Investigational New Drug, Mene Pangalos, multi-modular Treg cell therapy, Quell, Quell Therapeutics, T-regulator, T-regulatory cell engineering, T1D, Treg, type 1 diabetes
(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French company specializing in medical device design and manufacturing. The acquisition would be followed by a mandatory tender offer for all … Read the full press release
(IN BRIEF) According to an independent report, the cost of prescription medicines to the NHS in England reached a record high of £17.2 billion in the financial year 2021-2022. The report reveals that NHS spending on branded medicines has been … Read the full press release
Posted in Education, Government, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Beth Woods, cancer drugs, cost of prescription medicines, COVID-19 vaccines, Dr Huseyin Naci, Dr James Lomas, e Voluntary Scheme for Branded Medicines Pricing and Access, immunosuppression, London School of Economics and Political Science, London School of Hygiene & Tropical Medicine, LSE, LSHTM, malignant disease, medicines, NHS, REPORT, respiratory system disorders, University of York, VPAS
Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Acuitas Therapeutics, AskBio, Asklepios BioPharmaceutical, Bayer, Clinically validated, components, DNA, Dr. Thomas Madden, Friedemann Janus, gene editing, gene therapy, High potency ionizable lipid technology, Jost Reinhardt, lipid nanoparticle, LNP, LNP carriers, messenger RNA, molecular therapeutics, mRNA, RNA, vivo gene editing
Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and commercialize Cedilla’s CyclinE1/CDK2 complex inhibitors for precision oncology. These inhibitors target oncogenic drivers and offer a unique method of action, … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Bayer, CDK2, CDK2 inhibitors, Cedilla, Cedilla Therapeutics, Cyclin Dependent Kinase 2, cyclin E, CyclinE1, CyclinE1/CDK2 complex inhibitors, Dominik Ruettinger, Exclusive license agreement, M.D., Neil Exter, oncogenic drivers, Ph.D., precision oncology
(IN BRIEF) Loughborough University and the University of Oxford have collaborated on a groundbreaking study that has resulted in the development of a small molecule probe. This probe specifically binds to inositol pyrophosphate (5-PP-InsP5), a crucial cellular messenger involved in … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged 5-PP-InsP5, biological processes, cell growth, cellular messenger, Dr Felix Plasser, Dr Stephen Butler, enzyme regulation, Fathima Jamion, inositol pyrophosphate, Loughborough University, Megan Shipton, Pick of the Week, Professor Barry Potter, programmed cell death, regulator of blood glucose levels, small molecule probe, therapeutic drugs, University of Oxford
(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has granted a loan of $23 million to Meros Pharm, a leading pharmaceutical distributor in Uzbekistan. The loan will support Meros Pharm’s expansion plans by providing the necessary working capital … Read the full press release
Posted in Banks, Business, Financial, Investment, Pharma & Biotech, United Kingdom
Tagged EBRD, loan, Meros Pharm, pharmaceutical distributors, Uzbekistan
(IN BRIEF) Royal Philips is showcasing its end-to-end cardiology solutions at EuroPCR 2023 to deliver improved heart care with greater efficiency. The company’s comprehensive cardiology portfolio integrates imaging, devices, software, informatics, and services at every stage of the patient journey. … Read the full press release
Posted in France, Healthcare, Netherlands, Pharma & Biotech, Technology
Tagged angio iFR, AngioSculpt Evo, atherectomy solutions, Azurion, cardiology solutions, coronary imaging, coronary laser atherectomy catheter, DCR4Contrast, DEFINE-FLAIR, Dr. Takayuki Warisawa, Dr. Yoshinobu Onuma, Dynamic coronary roadmap, EchoNavigator, ELCA, EuroPCR, European Association of Percutaneous Cardiovascular Interventions, health technology, iFR, IntraSight, intravascular ultrasound, IVUS catheters, OmniWire, PCI patients, percutaneous coronary intervention, Philips Dynamic Coronary Roadmap, Prof. Javier Escaned, Radiographic imaging, ReVEAL iFR, Royal Philips, RX PTCA Scoring Balloon Catheter, SyncVision
HORIZON-RIA PROJECT GRANTED FOR THE EARLY DETECTION OF SEPSIS AT THE POINT-OF-CARE DISRUPTIVE SOLUTION FOR SEPSIS DIAGNOSIS AT THE POINT OF CARE THAT WILL OFFER MULTIPLEXED (WITHIN A SINGLE TEST) (IN BRIEF)The AMBROSIA project has been granted under the call … Read the full press release
Posted in Czech Republic, Education, European Union, France, Greece, Healthcare, Ireland, Netherlands, News, Pharma & Biotech, Science, Spain, Switzerland, Technology, United Kingdom
Tagged AMBROSIA, Argotech, Aristotle University of Thessaloniki, Biopix DNA Technology P.C., Catalan Institute of Nanoscience and Nanotechnology, diagnostics, Dr. Alexandros Pantazis, HORIZON-RIA, intelligent sepsis diagnosis, Ligentec, Microfluidics, microLIQUID, nucleic acids, Optical Sensor, PoC, PoC sepsis diagnostic unit, Point of Care, Prof. Nikos Pleros, SEPSIS, SMART PHOTONICS BV, University of Bourgogne, University of Ioannina, University of Southampton, Vall d'Hebron Research Institute, X-Celeprint
(IN BRIEF) Sandoz to commercialize six products exclusively in the US following distribution and collaboration agreement with Adalvo. The products are aimed at treating disorders that affect millions of people in the US each year, including antifungal/antibiotic, oncology, and pulmonary. … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech, Switzerland
Tagged Adalvo, Richard Saynor, Sandoz, treatments, US
(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release
(IN BRIEF) Krka, a Slovenian pharmaceutical company, has been awarded the title of the most energy-efficient company at the 25th conference of energy experts in Slovenia. The awards were given to Krka for its integrated, efficient, and sustainable management of … Read the full press release
Posted in Awards, Energy, Gas & Oil, Environment, Industrial, Management, News, Pharma & Biotech, Slovenia
Tagged Award, Dnevi energetikov conference, Krka, sustainable energy management
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?